Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Page 1
Predicting Major Adverse Events in Patients With Acute Myocardial Infarction.
Nestelberger T, Boeddinghaus J, Wussler D, Twerenbold R, Badertscher P, Wildi K, Miró Ò, López B, Martin-Sanchez FJ, Muzyk P, Koechlin L, Baumgartner B, Meier M, Troester V, Rubini Giménez M, Puelacher C, du Fay de Lavallaz J, Walter J, Kozhuharov N, Zimmermann T, Gualandro DM, Michou E, Potlukova E, Geigy N, Keller DI, Reichlin T, Mueller C; APACE Investigators. Nestelberger T, et al. J Am Coll Cardiol. 2019 Aug 20;74(7):842-854. doi: 10.1016/j.jacc.2019.06.025. J Am Coll Cardiol. 2019. PMID: 31416527 Free article.
BACKGROUND: Early and accurate detection of short-term major adverse cardiac events (MACE) in patients with suspected acute myocardial infarction (AMI) is an unmet clinical need. ...
BACKGROUND: Early and accurate detection of short-term major adverse cardiac events (MACE) in patients with suspected acute myocardia …
Prospective validation of prognostic and diagnostic syncope scores in the emergency department.
du Fay de Lavallaz J, Badertscher P, Nestelberger T, Isenrich R, Miró Ò, Salgado E, Geigy N, Christ M, Cullen L, Than M, Martin-Sanchez FJ, Bustamante Mandrión J, Di Somma S, Peacock WF, Kawecki D, Boeddinghaus J, Twerenbold R, Puelacher C, Wussler D, Strebel I, Keller DI, Poepping I, Kühne M, Mueller C, Reichlin T; BASEL IX Investigators; Giménez MR, Walter J, Kozhuharov N, Shrestha S, Mueller D, Sazgary L, Morawiec B, Muzyk P, Nowalany-Kozielska E, Freese M, Stelzig C, Meissner K, Kulangara C, Hartmann B, Ferel I, Sabti Z, Greenslade J, Hawkins T, Rentsch K, von Eckardstein A, Buser A, Kloos W, Lohrmann J, Osswald S. du Fay de Lavallaz J, et al. Among authors: stelzig c. Int J Cardiol. 2018 Oct 15;269:114-121. doi: 10.1016/j.ijcard.2018.06.088. Epub 2018 Jun 21. Int J Cardiol. 2018. PMID: 30224031
The CHADS(2)-score presented a higher or equally high accuracy for death in the long- and short-term follow-up than other syncope-specific risk scores. This score also performed well for the prediction of MACE in the long- and short-term evaluation and stratified pa …
The CHADS(2)-score presented a higher or equally high accuracy for death in the long- and short-term follow-up than other syncope-spe …
Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin.
Wildi K, Gimenez MR, Twerenbold R, Reichlin T, Jaeger C, Heinzelmann A, Arnold C, Nelles B, Druey S, Haaf P, Hillinger P, Schaerli N, Kreutzinger P, Tanglay Y, Herrmann T, Moreno Weidmann Z, Krivoshei L, Freese M, Stelzig C, Puelacher C, Rentsch K, Osswald S, Mueller C. Wildi K, et al. Among authors: stelzig c. Circulation. 2015 Jun 9;131(23):2032-40. doi: 10.1161/CIRCULATIONAHA.114.014129. Epub 2015 May 6. Circulation. 2015. PMID: 25948541 Free PMC article.
The incidence of inconsistencies was only 7.0% for assays with CDVs that were nearly biologically equivalent. Patients with inconsistent AMI had long-term mortality comparable to that of patients with consistent diagnoses (P=NS) and a trend toward higher long-term m …
The incidence of inconsistencies was only 7.0% for assays with CDVs that were nearly biologically equivalent. Patients with inconsistent AMI …
Utility of C-terminal proendothelin in the early diagnosis and risk stratification of patients with suspected acute myocardial infarction.
Haaf P, Zellweger C, Reichlin T, Zbinden A, Wildi K, Mosimann T, Twerenbold R, Reiter M, Balmelli C, Freidank H, Gimenez MR, Peter F, Freese M, Stelzig C, Hartmann B, Dinter C, Osswald S, Mueller C. Haaf P, et al. Among authors: stelzig c. Can J Cardiol. 2014 Feb;30(2):195-203. doi: 10.1016/j.cjca.2013.11.020. Epub 2013 Nov 23. Can J Cardiol. 2014. PMID: 24461921
The final diagnosis was adjudicated by 2 independent cardiologists. Patients were followed long-term for mortality. RESULTS: The adjudicated final diagnosis was AMI in 145 patients (22%). ...
The final diagnosis was adjudicated by 2 independent cardiologists. Patients were followed long-term for mortality. RESULTS: The adju …
Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays.
Haaf P, Reichlin T, Twerenbold R, Hoeller R, Rubini Gimenez M, Zellweger C, Moehring B, Fischer C, Meller B, Wildi K, Freese M, Stelzig C, Mosimann T, Reiter M, Mueller M, Hochgruber T, Sou SM, Murray K, Minners J, Freidank H, Osswald S, Mueller C. Haaf P, et al. Among authors: stelzig c. Eur Heart J. 2014 Feb;35(6):365-75. doi: 10.1093/eurheartj/eht218. Epub 2013 Jul 2. Eur Heart J. 2014. PMID: 23821402
CONCLUSION: High-sensitivity cardiac Troponin T is more accurate than hs-cTnI in the prediction of long-term mortality. Changes of hs-cTn do not seem to further improve risk stratification beyond initial presentation values....
CONCLUSION: High-sensitivity cardiac Troponin T is more accurate than hs-cTnI in the prediction of long-term mortality. Changes of hs …
Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study.
Lassus J, Gayat E, Mueller C, Peacock WF, Spinar J, Harjola VP, van Kimmenade R, Pathak A, Mueller T, Disomma S, Metra M, Pascual-Figal D, Laribi S, Logeart D, Nouira S, Sato N, Potocki M, Parenica J, Collet C, Cohen-Solal A, Januzzi JL Jr, Mebazaa A; GREAT-Network. Lassus J, et al. Int J Cardiol. 2013 Oct 3;168(3):2186-94. doi: 10.1016/j.ijcard.2013.01.228. Epub 2013 Mar 26. Int J Cardiol. 2013. PMID: 23538053
Biomarkers such as sST2, MR-proADM, natriuretic peptides and CRP, reflecting different pathophysiologic pathways, add prognostic value to clinical risk factors for predicting both short-term and one-year mortality in ADHF....
Biomarkers such as sST2, MR-proADM, natriuretic peptides and CRP, reflecting different pathophysiologic pathways, add prognostic value to cl …
Utility of 14 novel biomarkers in patients with acute chest pain and undetectable levels of conventional cardiac troponin.
Meune C, Balmelli C, Twerenbold R, Reiter M, Reichlin T, Ziller R, Drexler B, Stelzig C, Freese M, Wolf C, Haaf P, Osswald S, Mueller C. Meune C, et al. Among authors: stelzig c. Int J Cardiol. 2013 Aug 20;167(4):1164-9. doi: 10.1016/j.ijcard.2012.03.117. Epub 2012 Apr 15. Int J Cardiol. 2013. PMID: 22507551
The occurrence of death or acute myocardial infarction (AMI) (primary end point) and unplanned coronary revascularization (secondary endpoint) were recorded during long-term follow-up. RESULTS: During a mean follow-up of 668 241 days, death/AMI occurred in 23 patients (7%) …
The occurrence of death or acute myocardial infarction (AMI) (primary end point) and unplanned coronary revascularization (secondary endpoin …
Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure.
Arenja N, Reichlin T, Drexler B, Oshima S, Denhaerynck K, Haaf P, Potocki M, Breidthardt T, Noveanu M, Stelzig C, Heinisch C, Twerenbold R, Reiter M, Socrates T, Mueller C. Arenja N, et al. Among authors: stelzig c. J Intern Med. 2012 Jun;271(6):598-607. doi: 10.1111/j.1365-2796.2011.02469.x. Epub 2011 Nov 11. J Intern Med. 2012. PMID: 21988283 Free article.
CONCLUSIONS: Sensitive cardiac troponin I is a strong predictor of short- and long-term prognosis in AHF that helps to reclassify patients in terms of mortality risk. ...
CONCLUSIONS: Sensitive cardiac troponin I is a strong predictor of short- and long-term prognosis in AHF that helps to reclassify pat …
N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
Haaf P, Balmelli C, Reichlin T, Twerenbold R, Reiter M, Meissner J, Schaub N, Stelzig C, Freese M, Paniz P, Meune C, Drexler B, Freidank H, Winkler K, Hochholzer W, Mueller C. Haaf P, et al. Among authors: stelzig c. Am J Med. 2011 Aug;124(8):731-9. doi: 10.1016/j.amjmed.2011.02.035. Am J Med. 2011. PMID: 21787902
The final diagnosis was adjudicated by 2 independent cardiologists. Patients were followed long term regarding mortality. RESULTS: Acute myocardial infarction was the adjudicated final diagnosis in 117 patients (18%). ...
The final diagnosis was adjudicated by 2 independent cardiologists. Patients were followed long term regarding mortality. RESULTS: Ac …
B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain.
Haaf P, Reichlin T, Corson N, Twerenbold R, Reiter M, Steuer S, Bassetti S, Winkler K, Stelzig C, Heinisch C, Drexler B, Freidank H, Mueller C. Haaf P, et al. Among authors: stelzig c. Am J Med. 2011 May;124(5):444-52. doi: 10.1016/j.amjmed.2010.11.012. Am J Med. 2011. PMID: 21531234
The final diagnosis was adjudicated by 2 independent cardiologists. Patients were followed long term regarding mortality. RESULTS: Acute myocardial infarction was the adjudicated final diagnosis in 168 patients (16%). ...
The final diagnosis was adjudicated by 2 independent cardiologists. Patients were followed long term regarding mortality. RESULTS: Ac …
12 results